TG Therapeutics, Inc. (TGTX)
33.52
-0.06
(-0.16%)
USD |
NASDAQ |
Apr 02, 16:00
33.52
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Research and Development Expense (TTM) : 160.22M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Precision BioSciences, Inc. | 52.87M |
| Krystal Biotech, Inc. | 55.08M |
| Amicus Therapeutics, Inc. | 135.84M |
| Geron Corp. | 73.72M |
| MannKind Corp. | 66.35M |